Posted:
11/21/2025, 1:14:39 AM
Location(s):
Lisbon, Portugal ⋅ England, United Kingdom ⋅ Tartu, Estonia ⋅ Cambridge, England, United Kingdom ⋅ Gauteng, South Africa ⋅ Brussels-Capital, Belgium ⋅ Istanbul, Turkey ⋅ Bellville, Western Cape, South Africa ⋅ Central Denmark Region, Denmark ⋅ Riga, Latvia ⋅ Budapest, Budapest, Hungary ⋅ Sofia, Sofia-City, Bulgaria ⋅ Bloemfontein, Free State, South Africa ⋅ Hainaut, Belgium ⋅ Ile-de-France, France ⋅ Vienna, Austria ⋅ Dortmund, North Rhine-Westphalia, Germany ⋅ Brussels, Brussels-Capital, Belgium ⋅ Livingston, Scotland, United Kingdom ⋅ Bochum, North Rhine-Westphalia, Germany ⋅ Reading, England, United Kingdom ⋅ Masovian Voivodeship, Poland ⋅ Amsterdam, North Holland, Netherlands ⋅ Charleroi, Hainaut, Belgium ⋅ Hesse, Germany ⋅ Rome, Lazio, Italy ⋅ Manchester, England, United Kingdom ⋅ Athens, Attica, Greece ⋅ Attica, Greece ⋅ Emilia-Romagna, Italy ⋅ Bratislava, Region of Bratislava, Slovakia ⋅ Utrecht, Netherlands ⋅ The Borough District of Wexford, Ireland ⋅ Centurion, Gauteng, South Africa ⋅ Capital Region of Denmark, Denmark ⋅ Madrid, Community of Madrid, Spain ⋅ Milan, Lombardy, Italy ⋅ Western Cape, South Africa ⋅ North Holland, Netherlands ⋅ Brighton, England, United Kingdom ⋅ Leeds, England, United Kingdom ⋅ Bordeaux, Nouvelle-Aquitaine, France ⋅ Ljubljana, Slovenia ⋅ North Rhine-Westphalia, Germany ⋅ Berchem-Sainte-Agathe - Sint-Agatha-Berchem, Brussels-Capital, Belgium ⋅ Lombardy, Italy ⋅ Frankfurt, Hesse, Germany ⋅ Aarhus, Central Denmark Region, Denmark ⋅ City of Zagreb, Croatia ⋅ Berlin, Germany ⋅ Greater London, England, United Kingdom ⋅ Utrecht, Utrecht, Netherlands ⋅ Free State, South Africa ⋅ Region of Bratislava, Slovakia ⋅ Community of Madrid, Spain ⋅ Leinster, Ireland ⋅ Istanbul, Istanbul, Turkey ⋅ Bath, England, United Kingdom ⋅ Stockholm, Sweden ⋅ Sofia-City, Bulgaria ⋅ Lazio, Italy ⋅ Paris, Ile-de-France, France ⋅ Copenhagen, Capital Region of Denmark, Denmark ⋅ Scotland, United Kingdom ⋅ Gothenburg, Sweden ⋅ Tallinn, Estonia ⋅ Dublin, Leinster, Ireland ⋅ Budapest, Hungary ⋅ Nouvelle-Aquitaine, France
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
Business & Strategy
Senior Business Systems Analyst/Product Owner
IQVIA Laboratories
IQVIA Laboratories is a global leader in drug discovery and development, offering comprehensive central and specialty biomarker services. Our expertise includes genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine, vaccine assays, ADME, and bioanalytical services. We also specialise in antibody and biomarker discovery and decentralized clinical trial solutions. Committed to scientific rigor and operational excellence, we support all phases of drug development, ensuring high data integrity and accelerating transformative therapies.
Join us on our exciting journey!
Job Overview:
Define the scope and objectives of business systems through research and collaboration with stakeholders.
Analyse user needs and adjust system logic to enhance efficiency and performance.
Oversee business systems projects from inception through implementation and support.
Design PowerBI dashboards and functional prototypes to support data-driven requirements gathering.
Extract, query, and interpret complex lab data using SQL to inform clinical and operational decisions.
Translate technical infrastructure requirements into accessible documentation and actionable plans.
Foster cross-functional collaboration to align technology with business goals in clinical trial settings.
Requirements:
Benefits of joining IQVIA
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
Website: https://iqvia.com/
Headquarter Location: Danbury, Connecticut, United States
Employee Count: 10001+
Year Founded: 1982
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Analytics ⋅ Health Care ⋅ Life Science